Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Use of Stromal Vascular Fraction in Multiple Sclerosis [NA]

View source ↗

Summary

A clinical trial evaluating stromal vascular fraction for multiple sclerosis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stromal Vascular Fraction (stromal vascular fraction)

Snippet

Sponsor: Healeon Medical Inc | Conditions: Multiple Sclerosis, Autoimmune | NA | Status: SUSPENDED